Teglicar is a selective and reversible orally active liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1) inhibitor with an IC50 value of 0.68 µM and a Ki value of 0.36 µM. Teglicar has a potential antihyperglycemic propert. Teglicar can be used for the research of diabetes and neurodegenerative disease including Huntingtons disease (HD)[1][2].
Molecular Weight:
399.61
Purity:
98
CAS Number:
[250694-07-6]
Formula:
C22H45N3O3
Target:
Endogenous Metabolite
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted